Pharmacokinetics of lactosaminated recombinant human growth hormone in mice

被引:0
|
作者
Li, YC [1 ]
Guan, CT
Zhao, KQ
Chen, ZL
Li, TL
机构
[1] Sichuan Univ, W China Med Ctr, Affiliated Hosp 1, Dept Nucl Med, Chengdu 610041, Peoples R China
[2] Sichuan Normal Univ, Dept Chem, Chengdu 610066, Peoples R China
[3] Sichuan Univ, W China Med Ctr, Coll Pharm, Chengdu 610041, Peoples R China
[4] Sichuan Univ, W China Med Ctr, Affiliated Hosp 1, Dept Pharm, Chengdu 610041, Peoples R China
来源
ACTA PHARMACOLOGICA SINICA | 2001年 / 22卷 / 05期
关键词
somatotropin; pharmacokinetics; recombinant proteins;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
AIM: To study the pharmacokinetic characteristics of lactosaminated recombinant human growth hormone (hGH-L) in mice. METHODS: The biodistribution was studied with in vivo radioactive tracer technique. The pharmacokinetics was investigated by radioimmunoassy (RIA) method of hGH-L. The results were compared with that of recombinant human growth hormone (hGH). RESULTS: I-125-hGH-L has remarkable livertaxis. The area under drug concentration-time curve (32686.9 mug . min . L-1) in blood and serum mean residence time (21.4 min) of hGH-L are less than that of hGH (36913. 1 mug . min . L-1 and 24. 9 min) (P < 0.05). In target organ liver, hGH-L distribution half life (1.8 min) and elimination half life (11.1 min) are shorter than that of hGH (2.1 min and 27.7 min) (P < 0.05). The area under drug concentration-time curve (11621.9 mug . min L-1) of hGH-L is bigger than that of hGH (12148. 2 mug . min . L-1) (P < 0. 05) in liver. CONCLUSION: The pharmacokinetic paramters of hGH-L has obvious advantage over that of hGH.
引用
收藏
页码:450 / 454
页数:5
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF RECOMBINANT HUMAN GROWTH-HORMONE (SOMATOTROPIN)
    WIDLUND, L
    GUILBAUD, O
    WILTON, P
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1988, 10 (01) : 52 - 52
  • [2] Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
    Hou, Ling
    Chen, Zhi-hang
    Liu, Dong
    Cheng, Yuan-guo
    Luo, Xiao-ping
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 13 - 21
  • [3] Pharmacokinetics of Recombinant Human Growth Hormone (rhGH) in Beagles by ELISA
    Qian, Yueyue
    Shao, Qing
    Xu, Quanyu
    Qiao, Hongqun
    CURRENT PHARMACEUTICAL ANALYSIS, 2020, 16 (08) : 1112 - 1120
  • [4] Determination and Pharmacokinetics of Recombinant Human Growth Hormone in Rabbit Plasma by Spectrofluorometry Method
    Yilmaz, Bilal
    Kadioglu, Yucel
    Meral, Kadem
    Celebi, Fikret
    Onganer, Yavuz
    KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2012, 18 (04) : 589 - 594
  • [5] EFFICACY AND PHARMACOKINETICS OF RECOMBINANT DNA DERIVED HUMAN GROWTH-HORMONE IN RATS AND MONKEYS
    STEBBING, N
    FENNO, JT
    SANDA, M
    PEDIATRIC RESEARCH, 1981, 15 (12) : 1541 - 1541
  • [7] Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice
    Dao-Ming Liang
    Jia-Yong Chen
    Yi Zhang
    Ping Gan
    Jie Lin
    An-Bao Chen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (24) : 3810 - 3813
  • [8] Pharmacokinetics and pharmacodynamics of recombinant human growth hormone by subcutaneous jet- or needle-injection in patients with growth hormone deficiency
    Houdijk, ECAM
    Herdes, E
    Delemarre-Van de Waal, HA
    ACTA PAEDIATRICA, 1997, 86 (12) : 1301 - 1307
  • [9] Whither recombinant human growth hormone?
    Mantzoros, CS
    Moses, AC
    ANNALS OF INTERNAL MEDICINE, 1996, 125 (11) : 932 - 934
  • [10] RECOMBINANT HUMAN GROWTH-HORMONE
    FRYKLUND, LM
    BIERICH, JR
    RANKE, MB
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1986, 15 (03): : 511 - 535